Orthomyxoviridae Infections
"Orthomyxoviridae Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Virus diseases caused by the ORTHOMYXOVIRIDAE.
| Descriptor ID |
D009976
|
| MeSH Number(s) |
C02.782.620
|
| Concept/Terms |
Orthomyxoviridae Infections- Orthomyxoviridae Infections
- Infections, Orthomyxoviridae
- Infection, Orthomyxoviridae
- Orthomyxoviridae Infection
- Infections, Orthomyxovirus
- Infection, Orthomyxovirus
- Orthomyxovirus Infection
- Orthomyxovirus Infections
|
Below are MeSH descriptors whose meaning is more general than "Orthomyxoviridae Infections".
Below are MeSH descriptors whose meaning is more specific than "Orthomyxoviridae Infections".
This graph shows the total number of publications written about "Orthomyxoviridae Infections" by people in this website by year, and whether "Orthomyxoviridae Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
| 2025 | 1 | 1 | 2 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Orthomyxoviridae Infections" by people in Profiles.
-
Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine. J Nanobiotechnology. 2026 Mar 30; 24(1).
-
Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity. J Immunol. 2026 01 21; 215(1).
-
Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype. Nat Microbiol. 2025 Jul; 10(7):1711-1722.
-
ß-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus. Nat Immunol. 2025 Feb; 26(2):174-187.
-
Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE. Nature. 2023 02; 614(7948):530-538.
-
Mitochondrial cyclophilin D promotes disease tolerance by licensing NK cell development and IL-22 production against influenza virus. Cell Rep. 2022 06 21; 39(12):110974.
-
Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci Immunol. 2022 01 28; 7(67):eabf5314.
-
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2022 01; 100(1):49-60.
-
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model. J Virol. 2022 01 26; 96(2):e0142121.
-
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat. Viruses. 2021 05 22; 13(6).